The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global RNAi Technology Market Research Report 2025
Synopsis
RNA interference is a relatively new concept in the field of medicine. It is a process in which the ribonucleic acid inhibits translation or gene expression by converting single-stranded mRNA to double stranded RNA, thereby neutralizing the target nucleic acids.
The global RNAi Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.97%, including software, hardware and services.
This report aims to provide a comprehensive presentation of the global market for RNAi Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Technology.
Report Scope
The RNAi Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNAi Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNAi Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Dicerna Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma
Calando
Silence Therapeutics
Gotham Therapeutics
Segment by Type
Cancer
Liver Disorders
Respiratory Disorders
Neurological Disorders
Autoimmune Disorders
Others
Segment by Application
Drug Discovery & Development
Therapeutics
Drug Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
RNA interference is a relatively new concept in the field of medicine. It is a process in which the ribonucleic acid inhibits translation or gene expression by converting single-stranded mRNA to double stranded RNA, thereby neutralizing the target nucleic acids.
The global RNAi Technology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduces polices and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.97%, including software, hardware and services.
This report aims to provide a comprehensive presentation of the global market for RNAi Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNAi Technology.
Report Scope
The RNAi Technology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global RNAi Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNAi Technology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Dicerna Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma
Calando
Silence Therapeutics
Gotham Therapeutics
Segment by Type
Cancer
Liver Disorders
Respiratory Disorders
Neurological Disorders
Autoimmune Disorders
Others
Segment by Application
Drug Discovery & Development
Therapeutics
Drug Delivery
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNAi Technology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNAi Technology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Cancer
1.2.3 Liver Disorders
1.2.4 Respiratory Disorders
1.2.5 Neurological Disorders
1.2.6 Autoimmune Disorders
1.2.7 Others
1.3 Market by Application
1.3.1 Global RNAi Technology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery & Development
1.3.3 Therapeutics
1.3.4 Drug Delivery
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNAi Technology Market Perspective (2019-2030)
2.2 RNAi Technology Growth Trends by Region
2.2.1 Global RNAi Technology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 RNAi Technology Historic Market Size by Region (2019-2024)
2.2.3 RNAi Technology Forecasted Market Size by Region (2025-2030)
2.3 RNAi Technology Market Dynamics
2.3.1 RNAi Technology Industry Trends
2.3.2 RNAi Technology Market Drivers
2.3.3 RNAi Technology Market Challenges
2.3.4 RNAi Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNAi Technology Players by Revenue
3.1.1 Global Top RNAi Technology Players by Revenue (2019-2024)
3.1.2 Global RNAi Technology Revenue Market Share by Players (2019-2024)
3.2 Global RNAi Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNAi Technology Revenue
3.4 Global RNAi Technology Market Concentration Ratio
3.4.1 Global RNAi Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNAi Technology Revenue in 2023
3.5 RNAi Technology Key Players Head office and Area Served
3.6 Key Players RNAi Technology Product Solution and Service
3.7 Date of Enter into RNAi Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 RNAi Technology Breakdown Data by Type
4.1 Global RNAi Technology Historic Market Size by Type (2019-2024)
4.2 Global RNAi Technology Forecasted Market Size by Type (2025-2030)
5 RNAi Technology Breakdown Data by Application
5.1 Global RNAi Technology Historic Market Size by Application (2019-2024)
5.2 Global RNAi Technology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America RNAi Technology Market Size (2019-2030)
6.2 North America RNAi Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America RNAi Technology Market Size by Country (2019-2024)
6.4 North America RNAi Technology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNAi Technology Market Size (2019-2030)
7.2 Europe RNAi Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe RNAi Technology Market Size by Country (2019-2024)
7.4 Europe RNAi Technology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNAi Technology Market Size (2019-2030)
8.2 Asia-Pacific RNAi Technology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific RNAi Technology Market Size by Region (2019-2024)
8.4 Asia-Pacific RNAi Technology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNAi Technology Market Size (2019-2030)
9.2 Latin America RNAi Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America RNAi Technology Market Size by Country (2019-2024)
9.4 Latin America RNAi Technology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNAi Technology Market Size (2019-2030)
10.2 Middle East & Africa RNAi Technology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa RNAi Technology Market Size by Country (2019-2024)
10.4 Middle East & Africa RNAi Technology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals RNAi Technology Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in RNAi Technology Business (2019-2024)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Dicerna Pharmaceuticals, Inc.
11.2.1 Dicerna Pharmaceuticals, Inc. Company Detail
11.2.2 Dicerna Pharmaceuticals, Inc. Business Overview
11.2.3 Dicerna Pharmaceuticals, Inc. RNAi Technology Introduction
11.2.4 Dicerna Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2019-2024)
11.2.5 Dicerna Pharmaceuticals, Inc. Recent Development
11.3 Arrowhead Pharmaceuticals, Inc.
11.3.1 Arrowhead Pharmaceuticals, Inc. Company Detail
11.3.2 Arrowhead Pharmaceuticals, Inc. Business Overview
11.3.3 Arrowhead Pharmaceuticals, Inc. RNAi Technology Introduction
11.3.4 Arrowhead Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2019-2024)
11.3.5 Arrowhead Pharmaceuticals, Inc. Recent Development
11.4 Ionis Pharmaceuticals, Inc.
11.4.1 Ionis Pharmaceuticals, Inc. Company Detail
11.4.2 Ionis Pharmaceuticals, Inc. Business Overview
11.4.3 Ionis Pharmaceuticals, Inc. RNAi Technology Introduction
11.4.4 Ionis Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2019-2024)
11.4.5 Ionis Pharmaceuticals, Inc. Recent Development
11.5 Quark Pharmaceuticals, Inc.
11.5.1 Quark Pharmaceuticals, Inc. Company Detail
11.5.2 Quark Pharmaceuticals, Inc. Business Overview
11.5.3 Quark Pharmaceuticals, Inc. RNAi Technology Introduction
11.5.4 Quark Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2019-2024)
11.5.5 Quark Pharmaceuticals, Inc. Recent Development
11.6 Arbutus Biopharma
11.6.1 Arbutus Biopharma Company Detail
11.6.2 Arbutus Biopharma Business Overview
11.6.3 Arbutus Biopharma RNAi Technology Introduction
11.6.4 Arbutus Biopharma Revenue in RNAi Technology Business (2019-2024)
11.6.5 Arbutus Biopharma Recent Development
11.7 Benitec Biopharma
11.7.1 Benitec Biopharma Company Detail
11.7.2 Benitec Biopharma Business Overview
11.7.3 Benitec Biopharma RNAi Technology Introduction
11.7.4 Benitec Biopharma Revenue in RNAi Technology Business (2019-2024)
11.7.5 Benitec Biopharma Recent Development
11.8 Calando
11.8.1 Calando Company Detail
11.8.2 Calando Business Overview
11.8.3 Calando RNAi Technology Introduction
11.8.4 Calando Revenue in RNAi Technology Business (2019-2024)
11.8.5 Calando Recent Development
11.9 Silence Therapeutics
11.9.1 Silence Therapeutics Company Detail
11.9.2 Silence Therapeutics Business Overview
11.9.3 Silence Therapeutics RNAi Technology Introduction
11.9.4 Silence Therapeutics Revenue in RNAi Technology Business (2019-2024)
11.9.5 Silence Therapeutics Recent Development
11.10 Gotham Therapeutics
11.10.1 Gotham Therapeutics Company Detail
11.10.2 Gotham Therapeutics Business Overview
11.10.3 Gotham Therapeutics RNAi Technology Introduction
11.10.4 Gotham Therapeutics Revenue in RNAi Technology Business (2019-2024)
11.10.5 Gotham Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global RNAi Technology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Cancer
Table 3. Key Players of Liver Disorders
Table 4. Key Players of Respiratory Disorders
Table 5. Key Players of Neurological Disorders
Table 6. Key Players of Autoimmune Disorders
Table 7. Key Players of Others
Table 8. Global RNAi Technology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global RNAi Technology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global RNAi Technology Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global RNAi Technology Market Share by Region (2019-2024)
Table 12. Global RNAi Technology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global RNAi Technology Market Share by Region (2025-2030)
Table 14. RNAi Technology Market Trends
Table 15. RNAi Technology Market Drivers
Table 16. RNAi Technology Market Challenges
Table 17. RNAi Technology Market Restraints
Table 18. Global RNAi Technology Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global RNAi Technology Market Share by Players (2019-2024)
Table 20. Global Top RNAi Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technology as of 2023)
Table 21. Ranking of Global Top RNAi Technology Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by RNAi Technology Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players RNAi Technology Product Solution and Service
Table 25. Date of Enter into RNAi Technology Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global RNAi Technology Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global RNAi Technology Revenue Market Share by Type (2019-2024)
Table 29. Global RNAi Technology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global RNAi Technology Revenue Market Share by Type (2025-2030)
Table 31. Global RNAi Technology Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global RNAi Technology Revenue Market Share by Application (2019-2024)
Table 33. Global RNAi Technology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global RNAi Technology Revenue Market Share by Application (2025-2030)
Table 35. North America RNAi Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America RNAi Technology Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America RNAi Technology Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe RNAi Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe RNAi Technology Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe RNAi Technology Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific RNAi Technology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific RNAi Technology Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific RNAi Technology Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America RNAi Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America RNAi Technology Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America RNAi Technology Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa RNAi Technology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa RNAi Technology Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa RNAi Technology Market Size by Country (2025-2030) & (US$ Million)
Table 50. Alnylam Pharmaceuticals Company Detail
Table 51. Alnylam Pharmaceuticals Business Overview
Table 52. Alnylam Pharmaceuticals RNAi Technology Product
Table 53. Alnylam Pharmaceuticals Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 54. Alnylam Pharmaceuticals Recent Development
Table 55. Dicerna Pharmaceuticals, Inc. Company Detail
Table 56. Dicerna Pharmaceuticals, Inc. Business Overview
Table 57. Dicerna Pharmaceuticals, Inc. RNAi Technology Product
Table 58. Dicerna Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 59. Dicerna Pharmaceuticals, Inc. Recent Development
Table 60. Arrowhead Pharmaceuticals, Inc. Company Detail
Table 61. Arrowhead Pharmaceuticals, Inc. Business Overview
Table 62. Arrowhead Pharmaceuticals, Inc. RNAi Technology Product
Table 63. Arrowhead Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 64. Arrowhead Pharmaceuticals, Inc. Recent Development
Table 65. Ionis Pharmaceuticals, Inc. Company Detail
Table 66. Ionis Pharmaceuticals, Inc. Business Overview
Table 67. Ionis Pharmaceuticals, Inc. RNAi Technology Product
Table 68. Ionis Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 69. Ionis Pharmaceuticals, Inc. Recent Development
Table 70. Quark Pharmaceuticals, Inc. Company Detail
Table 71. Quark Pharmaceuticals, Inc. Business Overview
Table 72. Quark Pharmaceuticals, Inc. RNAi Technology Product
Table 73. Quark Pharmaceuticals, Inc. Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 74. Quark Pharmaceuticals, Inc. Recent Development
Table 75. Arbutus Biopharma Company Detail
Table 76. Arbutus Biopharma Business Overview
Table 77. Arbutus Biopharma RNAi Technology Product
Table 78. Arbutus Biopharma Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 79. Arbutus Biopharma Recent Development
Table 80. Benitec Biopharma Company Detail
Table 81. Benitec Biopharma Business Overview
Table 82. Benitec Biopharma RNAi Technology Product
Table 83. Benitec Biopharma Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 84. Benitec Biopharma Recent Development
Table 85. Calando Company Detail
Table 86. Calando Business Overview
Table 87. Calando RNAi Technology Product
Table 88. Calando Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 89. Calando Recent Development
Table 90. Silence Therapeutics Company Detail
Table 91. Silence Therapeutics Business Overview
Table 92. Silence Therapeutics RNAi Technology Product
Table 93. Silence Therapeutics Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 94. Silence Therapeutics Recent Development
Table 95. Gotham Therapeutics Company Detail
Table 96. Gotham Therapeutics Business Overview
Table 97. Gotham Therapeutics RNAi Technology Product
Table 98. Gotham Therapeutics Revenue in RNAi Technology Business (2019-2024) & (US$ Million)
Table 99. Gotham Therapeutics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNAi Technology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global RNAi Technology Market Share by Type: 2023 VS 2030
Figure 3. Cancer Features
Figure 4. Liver Disorders Features
Figure 5. Respiratory Disorders Features
Figure 6. Neurological Disorders Features
Figure 7. Autoimmune Disorders Features
Figure 8. Others Features
Figure 9. Global RNAi Technology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global RNAi Technology Market Share by Application: 2023 VS 2030
Figure 11. Drug Discovery & Development Case Studies
Figure 12. Therapeutics Case Studies
Figure 13. Drug Delivery Case Studies
Figure 14. Others Case Studies
Figure 15. RNAi Technology Report Years Considered
Figure 16. Global RNAi Technology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global RNAi Technology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global RNAi Technology Market Share by Region: 2023 VS 2030
Figure 19. Global RNAi Technology Market Share by Players in 2023
Figure 20. Global Top RNAi Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNAi Technology as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by RNAi Technology Revenue in 2023
Figure 22. North America RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America RNAi Technology Market Share by Country (2019-2030)
Figure 24. United States RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe RNAi Technology Market Share by Country (2019-2030)
Figure 28. Germany RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific RNAi Technology Market Share by Region (2019-2030)
Figure 36. China RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America RNAi Technology Market Share by Country (2019-2030)
Figure 44. Mexico RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa RNAi Technology Market Share by Country (2019-2030)
Figure 48. Turkey RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia RNAi Technology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Alnylam Pharmaceuticals Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 51. Dicerna Pharmaceuticals, Inc. Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 52. Arrowhead Pharmaceuticals, Inc. Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 53. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 54. Quark Pharmaceuticals, Inc. Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 55. Arbutus Biopharma Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 56. Benitec Biopharma Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 57. Calando Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 58. Silence Therapeutics Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 59. Gotham Therapeutics Revenue Growth Rate in RNAi Technology Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
